Stock Price
1.49
Daily Change
0.02 1.36%
Monthly
12.88%
Yearly
-49.15%
Q1 Forecast
1.33

Geron reported $47.2M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Amgen USD 9.9B 340M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Cytokinetics USD 1.93M 64.83M Sep/2025
Exelixis USD 597.8M 29.5M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
Geron USD 47.2M 1.8M Sep/2025
Gilead Sciences USD 7.8B 700M Sep/2025
Incyte USD 1.37B 310M Sep/2025
MacroGenics USD 72.84M 50.6M Sep/2025
Novartis USD 13.91B 144M Sep/2025